Pulocimab

Pulocimab is an anti-VEGFR2 monoclonal antibody (mAb) . Pulocimab can be used for the research of cancers[1].

Product Specifications

CAS Number

[2428381-49-9]

Product Name Alternative

AK-109

UNSPSC

12352203

Target

VEGFR

Type

Inhibitory Antibodies

Related Pathways

Protein Tyrosine Kinase/RTK

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/pulocimab.html

Purity

98.42

Solubility

10 mM in DMSO

Smiles

[Pulocimab]

Molecular Weight

(143.721 kDa)

References & Citations

[1]Keam SJ. Cadonilimab: First Approval. Drugs. 2022 Aug;82 (12) :1333-1339.

Shipping Conditions

Dry Ice

Storage Conditions

Store at -80°C for 2 years

Scientific Category

Inhibitory Antibodies

Clinical Information

Phase 3

Isoform

VEGFR2/KDR/Flk-1

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

22061041-1 2 μg

High Mobility Group AT-Hook 1 Human (Recombinant)

Ask

View Details

KN514157 1 Kit

Disp3 Mouse Gene Knockout Kit (CRISPR)

Ask

View Details

abx966077-01 150 µg

Human BMPER shRNA Plasmid

Ask

View Details

abx966077-02 300 µg

Human BMPER shRNA Plasmid

Ask

View Details

NBP1-47272PCP 0.1 mL

Rabbit Polyclonal SMG5 Antibody [PerCP]

Ask

View Details

SI003876B 1 Each

Human CYBA Pre-designed siRNA Set B

Ask

View Details